The Iron Chelator Deferoxamine Prevents Cisplatin-Induced Lipid Peroxidation in Rat Kidney Cortical Slices
Yoshiko Kameyama, Munekazu Gemba
Abstract
Yoshiko Kameyama, Munekazu Gemba
Abstract
We evaluated the effect of the iron chelator deferoxamine on lipid peroxidation produced by the nephrotoxic antineoplastic drug cisplatin in rat kidney cortical slices. The addition of deferoxamine to the incubation medium prevented such lipid peroxidation in the incubated slices. Treatment of rats with deferoxamine inhibited the increase in lipid peroxidation caused by cisplatin in the medium. These results suggest that iron may be a causal agent of cisplatin-induced lipid peroxidation.
OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We evaluated the effect of the iron chelator deferoxamine on lipid peroxidation produced by the nephrotoxic antineoplastic drug cisplatin in rat kidney cortical slices. The addition of deferoxamine to the incubation medium prevented such lipid peroxidation in the incubated slices. Treatment of rats with deferoxamine inhibited the increase in lipid peroxidation caused by cisplatin in the medium. These results suggest that iron may be a causal agent of cisplatin-induced lipid peroxidation.
Key concepts: Deferoxamine, Lipid peroxidation, Cisplatin, Chemistry, Pharmacology, Nephrotoxicity, Chelation, Biochemistry